• Improves QIVIVE & toxicity evaluations
    • Influences pharmacokinetic properties
    • Determines the effective concentration Cfree

    The database development started in 2005, it now contains:

    • > 17.000 data records
    • > 7.200 diverse compound structures
    • taken from > 2.400 scientific publications

    Plasma Protein Binding Database

    Drugs and toxic substances can be bound to proteins in plasma or blood, which reduces the free (effective) concentration of compounds in vivo. For toxicity evaluations and in drug discovery it is important to know to which extend a compound is bound to plasma proteins (PPB%):

    Data records are comprehensively curated and annotated with up to 20 data fields describing the species, exp. conditions & methods (EQ, UF, UC, GF, albumin binding), compound concentration, etc.

    Reliable models to forecast plasma protein binding (PPB%) of substances have been created and show a high quality of prediction. We found a low Mean Absolute Error (MAE) and a high correlation between experimental and predicted PPB values based on a large and independent validation dataset. Contact us for further details (email).

    The project results  were presented in January 2020 at the BMBF-Statusseminar in Berlin.


Plasma protein binding data from different species:

© Copyright 2004-2020 PharmaInformatic Boomgaarden. All rights reserved.           Site map           Contact         Terms of Use         Imprint        



Quantitative In Vitro to In Vivo Extrapolation

In order to correlate
IN VITRO results
 IN VIVO observations, plasma protein binding
of a compound
is needed.

The effective
Cfree or Cunbound
 can be largely different
from the nominal concentration
of compounds due to
plasma protein binding.